首页> 外文OA文献 >Vitaminï¿½D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model

【2h】

Vitaminï¿½D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model

机译：维生素率为549非小细胞肺癌模型中的细胞抑制剂与酪氨酸激酶抑制剂的抗癌和抗血管生成活性提高抗血糖激酶抑制剂

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Ewa Maj; Beata Filip-Psurska; Magdalena Milczarek; Mateusz Psurski; Andrzej Kutner; Joanna Wietrzyk;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model [J] . Ewa Maj, Beata Filip-Psurska, Magdalena Milczarek, International journal of oncology . 2018,第2期

机译：在A549非小细胞肺癌模型中，维生素D衍生物可增强酪氨酸激酶抑制剂与抑癌药物的抗癌和抗血管生成活性
2. Enhanced anti-angiogenic effect of E7820 in combination with erlotinib in epidermal growth factor receptor-tyrosine kinase inhibitor-resistant non-small-cell lung cancer xenograft models [J] . Ito Ken, Semba Taro, Uenaka Toshimitsu, Cancer science. . 2014,第8期

机译：E7820联合厄洛替尼在表皮生长因子受体酪氨酸激酶抑制剂耐药的非小细胞肺癌异种移植模型中的增强抗血管生成作用
3. The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer [J] . Smith Donald L., Acquaviva Jaime, Sequeira Manuel, Targeted oncology . 2015,第2期

机译：HSP90抑制剂ganetespib增强EGFR酪氨酸激酶抑制作用在突变型和野生型非小细胞肺癌中的抗肿瘤活性
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。
6. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model [O] . Ewa Maj, Beata Filip-Psurska, Magdalena Milczarek, -1

机译：在A549非小细胞肺癌模型中维生素D衍生物可增强酪氨酸激酶抑制剂与抑癌药物的抗癌和抗血管生成活性
7. The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer [O] . Donald L. Smith, Jaime Acquaviva, Manuel Sequeira, 2014

机译：HSP90抑制剂ganetespib增强EGFR酪氨酸激酶抑制在突变型和野生型非小细胞肺癌中的抗肿瘤活性

Vitaminï¿½D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model

著录项

相似文献

相关主题

期刊订阅